Review



pe-cyanine7 klrg1 monoclonal antibody (2f1)  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher pe-cyanine7 klrg1 monoclonal antibody (2f1)
    Defective ILC3 function in IRF4-deficient mice drives C. rodentium and C. albicans infection in a cell-intrinsic manner (A–F) NCG mice were adoptively transferred with 80,000 intestinal ILC3s (Lin − CD127 + CD27 − <t>KLRG1</t> − ) sorted from the small intestine of Irf4 f/f and Irf4 f/f Rorc cre mice or PBS as control after being treated with ABX for 1 week. ILC3s were stimulated with IL-23 and IL-1β for 30 min before injected into NCG mice through the tail vein. NCG mice were orally inoculated with C. rodentium 24 h after adoptive transfer. (A, B) Measurements (A) and statistical analysis (B) of the colon lengths from NCG recipients ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (C) CFUs in the feces of NCG recipients 9 days after infection ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (D) Changes in body weight were recorded at the indicated time points ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (E) H&E staining of colon tissue sections. (F) Pathological score of colon histology. (G–L) Irf4 f/f or Irf4 f/f Rorc cre ILC3s were adoptively transferred into NCG mice with C. albicans infection. (G and H) Measurements (G) and statistical analysis (H) of the colon lengths from NCG recipients ( n = 2 control, n = 4 transferred). (I) Fecal fungal burden ( n = 3 control, n = 4 transferred). (J) Variations of body weight were shown each day ( n = 4). (K) Pathological score of colon histology. (L) Histological analysis of colonic tissues by H&E staining. The data are representative of at least two independent experiments (A–L). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .
    Pe Cyanine7 Klrg1 Monoclonal Antibody (2f1), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/klrg1/anti+klrg1/pmc12205599-22-0-6
    Average 90 stars, based on 1 article reviews
    pe-cyanine7 klrg1 monoclonal antibody (2f1) - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "The transcription factor IRF4 regulates the homeostasis and function of intestinal ILC3s"

    Article Title: The transcription factor IRF4 regulates the homeostasis and function of intestinal ILC3s

    Journal: iScience

    doi: 10.1016/j.isci.2025.112800

    Defective ILC3 function in IRF4-deficient mice drives C. rodentium and C. albicans infection in a cell-intrinsic manner (A–F) NCG mice were adoptively transferred with 80,000 intestinal ILC3s (Lin − CD127 + CD27 − KLRG1 − ) sorted from the small intestine of Irf4 f/f and Irf4 f/f Rorc cre mice or PBS as control after being treated with ABX for 1 week. ILC3s were stimulated with IL-23 and IL-1β for 30 min before injected into NCG mice through the tail vein. NCG mice were orally inoculated with C. rodentium 24 h after adoptive transfer. (A, B) Measurements (A) and statistical analysis (B) of the colon lengths from NCG recipients ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (C) CFUs in the feces of NCG recipients 9 days after infection ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (D) Changes in body weight were recorded at the indicated time points ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (E) H&E staining of colon tissue sections. (F) Pathological score of colon histology. (G–L) Irf4 f/f or Irf4 f/f Rorc cre ILC3s were adoptively transferred into NCG mice with C. albicans infection. (G and H) Measurements (G) and statistical analysis (H) of the colon lengths from NCG recipients ( n = 2 control, n = 4 transferred). (I) Fecal fungal burden ( n = 3 control, n = 4 transferred). (J) Variations of body weight were shown each day ( n = 4). (K) Pathological score of colon histology. (L) Histological analysis of colonic tissues by H&E staining. The data are representative of at least two independent experiments (A–L). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .
    Figure Legend Snippet: Defective ILC3 function in IRF4-deficient mice drives C. rodentium and C. albicans infection in a cell-intrinsic manner (A–F) NCG mice were adoptively transferred with 80,000 intestinal ILC3s (Lin − CD127 + CD27 − KLRG1 − ) sorted from the small intestine of Irf4 f/f and Irf4 f/f Rorc cre mice or PBS as control after being treated with ABX for 1 week. ILC3s were stimulated with IL-23 and IL-1β for 30 min before injected into NCG mice through the tail vein. NCG mice were orally inoculated with C. rodentium 24 h after adoptive transfer. (A, B) Measurements (A) and statistical analysis (B) of the colon lengths from NCG recipients ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (C) CFUs in the feces of NCG recipients 9 days after infection ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (D) Changes in body weight were recorded at the indicated time points ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (E) H&E staining of colon tissue sections. (F) Pathological score of colon histology. (G–L) Irf4 f/f or Irf4 f/f Rorc cre ILC3s were adoptively transferred into NCG mice with C. albicans infection. (G and H) Measurements (G) and statistical analysis (H) of the colon lengths from NCG recipients ( n = 2 control, n = 4 transferred). (I) Fecal fungal burden ( n = 3 control, n = 4 transferred). (J) Variations of body weight were shown each day ( n = 4). (K) Pathological score of colon histology. (L) Histological analysis of colonic tissues by H&E staining. The data are representative of at least two independent experiments (A–L). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .

    Techniques Used: Infection, Control, Injection, Adoptive Transfer Assay, Staining, Two Tailed Test

    IRF4 deficiency compromises MHC class Ⅱ expression and further restrains ILC-mediated apoptosis of effector CD4 + T cells both in vitro and in vivo (A) Violin plots visualizing the expression of MHC-class-Ⅱ-related signature genes. (B) FACS analysis and MFI of MHC class Ⅱ expression in ILC3s isolated from Irf4 f/f and Irf4 f/f Rorc cre mice ( n = 6). ILC3 subsets were gated as Lin − RORγt + and then CCR6 + NKp46 − , CCR6 − NKp46 + , or CCR6 − NKp46 − . The lineage cocktail included TCRγδ, CD3ε, CD19, CD5, CD11c, Gr-1, and Ter119. (C and D) Activated OT-Ⅱ CD4 + T cells were cultured ex vivo with purified ILC3s from the siLP of Irf4 f/f and Irf4 f/f Rorc cre mice in the presence or absence of Ova peptide or the anti-MHC class Ⅱ neutralizing antibody. (C) Quantification of OT-Ⅱ T cells recovery (%). (D) Quantification of Annexin-V + OT-Ⅱ T cells. (E and F) Naive CD4-positive T cells (gating as CD4 + CD25 − CD62L hi CD44 lo cells) were sorted from OT-Ⅱ mice and pre-activated overnight. After pre-activation, CD4 positive T cells were transplanted into recipient Irf4 f/f and Irf4 f/f Rorc cre mice along with OVA peptide administration every 2 days following transfer. Nine days later, mice were sacrificed for further analysis of OT-Ⅱ CD4 + T cells (gating as CD8 − CD4 + TCRβ + Vβ5 + ) transferred in the spleen, mLN, siLPL, and cLPL of recipient mice. (G) One hundred thousand intestinal ILC3s (Lin − CD127 + CD27 − KLRG1 − ) were sorted from Irf4 f/f or Irf4 f/f Rorc cre mice and transferred with 500,000 activated OT-ⅡCD4 + T cells into NCG mice, flowing by OVA peptide i.p. every 2 days. Nine days later, survived OT-ⅡCD4 + T cells were quantified. ( n = 2 APC, n = 5 transferred group). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. The data are representative of at least three independent experiments (B–G). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .
    Figure Legend Snippet: IRF4 deficiency compromises MHC class Ⅱ expression and further restrains ILC-mediated apoptosis of effector CD4 + T cells both in vitro and in vivo (A) Violin plots visualizing the expression of MHC-class-Ⅱ-related signature genes. (B) FACS analysis and MFI of MHC class Ⅱ expression in ILC3s isolated from Irf4 f/f and Irf4 f/f Rorc cre mice ( n = 6). ILC3 subsets were gated as Lin − RORγt + and then CCR6 + NKp46 − , CCR6 − NKp46 + , or CCR6 − NKp46 − . The lineage cocktail included TCRγδ, CD3ε, CD19, CD5, CD11c, Gr-1, and Ter119. (C and D) Activated OT-Ⅱ CD4 + T cells were cultured ex vivo with purified ILC3s from the siLP of Irf4 f/f and Irf4 f/f Rorc cre mice in the presence or absence of Ova peptide or the anti-MHC class Ⅱ neutralizing antibody. (C) Quantification of OT-Ⅱ T cells recovery (%). (D) Quantification of Annexin-V + OT-Ⅱ T cells. (E and F) Naive CD4-positive T cells (gating as CD4 + CD25 − CD62L hi CD44 lo cells) were sorted from OT-Ⅱ mice and pre-activated overnight. After pre-activation, CD4 positive T cells were transplanted into recipient Irf4 f/f and Irf4 f/f Rorc cre mice along with OVA peptide administration every 2 days following transfer. Nine days later, mice were sacrificed for further analysis of OT-Ⅱ CD4 + T cells (gating as CD8 − CD4 + TCRβ + Vβ5 + ) transferred in the spleen, mLN, siLPL, and cLPL of recipient mice. (G) One hundred thousand intestinal ILC3s (Lin − CD127 + CD27 − KLRG1 − ) were sorted from Irf4 f/f or Irf4 f/f Rorc cre mice and transferred with 500,000 activated OT-ⅡCD4 + T cells into NCG mice, flowing by OVA peptide i.p. every 2 days. Nine days later, survived OT-ⅡCD4 + T cells were quantified. ( n = 2 APC, n = 5 transferred group). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. The data are representative of at least three independent experiments (B–G). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .

    Techniques Used: Expressing, In Vitro, In Vivo, Isolation, Cell Culture, Ex Vivo, Purification, Activation Assay, Two Tailed Test

    Related Articles

    Flow Cytometry:

    Article Title: Neuroimmune characterization of optineurin insufficiency mouse model during ageing.
    Article Snippet: TMB (#ES001-500ML) was from Merck Millipore (Burlington, MA, USA). .. Flow cytometry anti-mouse antibodies against B220 (#103231), CD8a (#100744), CD25 (#101910), CD38 (#102707), CD44 (#103055), CD62L (#104431), CD69 (#104514), CD90.2 (#105331), FOXP3 (126404), IFN-γ (#505845), Ly-6G (#127606), MHC Class II (#107648) and NK.1.1 (#108739) were from BioLegend (San Diego, CA, USA), CD11c (#12-0114-82), CD45 (#11-0451-82), CD86 (#25-0862-80), F4/80 (#45-4801-82), KLRG1 (#11-5893-82), Ly-6C (#47-5932-82), TNF-α (#25-7321-82), IL17A (#12-7177-81), IL-2 (#17-7021-81), and FOXP3/Transcription Factor Staining Buffer Set (#00-5523-00), and Live/Dead dye (#65-0863-14) were purchased from eBioscience (San Diego, CA, USA); CD4 (#560181), CD11b (#553312), 2.4G2 (Fc block, #553142) and Perm/Wash Buffer (#554723) were from BD Pharmingen (San Diego, CA, USA). .. Perm/Wash buffer (#51-2091KZ) was from BD Biosciences (Franklin Lakes, NJ, USA).

    Article Title: TCF-1 and TOX regulate the memory formation of intestinal group 2 innate lymphoid cells in asthma.
    Article Snippet: .. Flow cytometry and cell sorting To analyze mice ILC2s, different combinations of antibodies against lineage markers (CD3ε, clone 145-2C11, Ly-6G/Ly-6C, clone RB6-8C5, CD11b, clone M1/70, CD45R/B220, clone RA3-6B2, TER-119/Erythroid cells, clone Ter-119; #133302; BioLegend; 1:200), CD45 (clone 30-F11; #25-0451-82; eBioscience; 1:500), CD90.2/Thy1.2 (clone 53-2.1; #64- 0902-82; eBioscience; 1:500), NK1.1 (clone PK136; #414-5941-82; eBioscience; 1:500), NKp46/CD335 (clone 29A1.4; #48-3351-82; eBioscience; 1:500), CD4 (clone RM4-5; #Q22165; eBioscience; 1:500), IL-33R/ST2 (clone RMST2-2; #63-9335-82; eBioscience; 1:200), GATA3 (clone TWAJ; #56-9966-42; eBioscience; 1:100), Rorγt (clone B2D; #61- 6981-82; eBioscience; 1:100), KLRG1 (clone 2F1; #46-5893-80; eBioscience; 1:200), IL-17RB (cloneMUNC33; #50-7361-82; eBioscience; 1:200), CD199/CCR9 (clone CW-1.2; #48-1991-82; eBioscience; 1:500), CD363/S1PR1 (clone SW4GYPP; #50-3639-42; eBioscience; 1:500), integrinα4β7 (clone DATK-32; #12-5887-82; eBioscience; 1:500), CD45.1 (clone A20; #48-0453-82; eBioscience; 1:500), Ki-67 (clone SolA15; #46- 5698-82; eBioscience; 1:500), IL-4 (clone 11B11; # 25-7041-82; eBioscience; 1:200), IL-5 (cloneTRFK5; #12-7052-81; eBioscience; 1:200), IL-13 (clone eBio13A; #47-7133-80; eBioscience; 1:200), TCF-1 (clone C.725.7; #MA5-14965; invitrogen; 1:200) and TOX (clone TXRX10; #12- 6502-82; Invitrogen; 1:200) or corresponding control isotypes were applied depending on the experiment. .. Cells were blocked with FcR Blocking Reagent (#130-092-575, Miltenyi Biotec), followed by 30min of staining with antibodies and with LIVE/DEAD Fixable aqua at 4 °C.

    Immunopeptidomics:

    Article Title: Neuroimmune characterization of optineurin insufficiency mouse model during ageing.
    Article Snippet: TMB (#ES001-500ML) was from Merck Millipore (Burlington, MA, USA). .. Flow cytometry anti-mouse antibodies against B220 (#103231), CD8a (#100744), CD25 (#101910), CD38 (#102707), CD44 (#103055), CD62L (#104431), CD69 (#104514), CD90.2 (#105331), FOXP3 (126404), IFN-γ (#505845), Ly-6G (#127606), MHC Class II (#107648) and NK.1.1 (#108739) were from BioLegend (San Diego, CA, USA), CD11c (#12-0114-82), CD45 (#11-0451-82), CD86 (#25-0862-80), F4/80 (#45-4801-82), KLRG1 (#11-5893-82), Ly-6C (#47-5932-82), TNF-α (#25-7321-82), IL17A (#12-7177-81), IL-2 (#17-7021-81), and FOXP3/Transcription Factor Staining Buffer Set (#00-5523-00), and Live/Dead dye (#65-0863-14) were purchased from eBioscience (San Diego, CA, USA); CD4 (#560181), CD11b (#553312), 2.4G2 (Fc block, #553142) and Perm/Wash Buffer (#554723) were from BD Pharmingen (San Diego, CA, USA). .. Perm/Wash buffer (#51-2091KZ) was from BD Biosciences (Franklin Lakes, NJ, USA).

    Staining:

    Article Title: Neuroimmune characterization of optineurin insufficiency mouse model during ageing.
    Article Snippet: TMB (#ES001-500ML) was from Merck Millipore (Burlington, MA, USA). .. Flow cytometry anti-mouse antibodies against B220 (#103231), CD8a (#100744), CD25 (#101910), CD38 (#102707), CD44 (#103055), CD62L (#104431), CD69 (#104514), CD90.2 (#105331), FOXP3 (126404), IFN-γ (#505845), Ly-6G (#127606), MHC Class II (#107648) and NK.1.1 (#108739) were from BioLegend (San Diego, CA, USA), CD11c (#12-0114-82), CD45 (#11-0451-82), CD86 (#25-0862-80), F4/80 (#45-4801-82), KLRG1 (#11-5893-82), Ly-6C (#47-5932-82), TNF-α (#25-7321-82), IL17A (#12-7177-81), IL-2 (#17-7021-81), and FOXP3/Transcription Factor Staining Buffer Set (#00-5523-00), and Live/Dead dye (#65-0863-14) were purchased from eBioscience (San Diego, CA, USA); CD4 (#560181), CD11b (#553312), 2.4G2 (Fc block, #553142) and Perm/Wash Buffer (#554723) were from BD Pharmingen (San Diego, CA, USA). .. Perm/Wash buffer (#51-2091KZ) was from BD Biosciences (Franklin Lakes, NJ, USA).

    Article Title: Immunogenicity and protection of a triple repeat domain III mRNA vaccine against Zika virus.
    Article Snippet: Representative images of the histopathological sections were captured using Aperio ImageScope Version 12.3 (Leica Biosystems, Buffalo Grove, IL, USA), and evaluated by a blinded histopathologist to ensure unbiased analysis. .. To determine effector T cell and B cell and splenocytes were isolated, blocked using CD16/CD32 (eBioscience) for 20 min at 4 ◦C and stained with CD8a (clone 53–6.7, BioLegend, San Diego, CA, USA), CD4 (clone GK1.5, BioLegend), CD25 (clone PC61.5, BioLegend), CD69 (clone H1.2F3, BioLegend), CD127 (clone A7R34, BioLegend), KLRG1 (clone 2F1, Invitrogen), CD19 (clone eBio1D3, eBioscience), CD138 (clone 281–2(Syndecan-1), BD Horizon), C73 (clone eBioTY/11.8, eBioscience), GL7 (clone GL7, BioLegend) and Fixable Viability Dye eFluor520 (eBioscience) for 30 min at 4 ◦C in the dark. ..

    Article Title: TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation
    Article Snippet: In some experiments , increasing doses of a STAT5 inhibitor (STAT5i; CAS 285986-31-4; # 573108; Calbiochem) were added to ILC2s stimulated with rIL-33, rTL1A, and rIL-2. .. Single-cell suspensions were stained for 30 min at 4°C with combinations of the following antibodies, diluted in FcR block (CD16/CD32 clone 2.4G2, # 553142, RRID: AB_394657; BD Biosciences): CD45 (clone 30F11, # 557235, RRID: AB_396609; BD Biosciences and # 17-0451-82, RRID: AB_469392; eBioscience), SiglecF (clone E50-2440, # 552126, RRID: AB_394341; BD Biosciences), CD4 (clone GK1.5, # 11-0041-85, RRID: AB_464892; eBioscience), CD19 (clone eBio1D3, # 561740, RRID: AB_396681; BD Biosciences), CD45R (clone RA3-6B2, # 553088, RRID: AB_394618; BD biosciences), NK1.1 (clone PK136, # 11-5941-85, RRID: AB_465318; eBioscience and # 108739, RRID:AB_2562273; Biolegend), CD3 (clone 17A2, # 11-0032-82, RRID: AB_2572431; eBioscience and eF450 # 48-0032-82, RRID: AB_1272193; eBioscience), CD11b (clone M1/70, # 11-0112-85, RRID: AB_464936; eBioscience), Ter119 (clone Ter119, # 11-5921-85, RRID: AB_465311; eBioscience), Ly-6G/Ly6C (Gr-1, clone RB6-8C5, # 11-5931-81, RRID: AB_465313; eBioscience), FcεRIa (clone MAR-1, # 11-5898-85, RRID: AB_465308; eBioscience), CD11c (clone N418, # 11-0114-85, RRID: AB_464941; eBioscience and # 17-0114-82, RRID: AB_469346), CD90.2 (clone 53–2.1, # 561641, RRID: AB_10898013; BD Biosciences), Sca-1 (clone D7, # 17-5981-83, RRID: AB_469488; eBioscience), CD25 (clone PC61.5, # 48-0251-82, RRID: AB_10671550; eBioscience), CD127 (clone A7R34, # 12-1,271-82, RRID: AB_465844; eBioscience), KLRG1 (clone 2F1, # 17-5893-81, RRID: AB_469469; eBioscience), ICOS (clone 7E-17G9, # 12-9942-82, RRID: AB_466274; eBioscience), DR3 (clone 4C12, # 144405, RRID: AB_2561688; Biolegend), CD200 (clone OX-90, # 123807, RRID: AB_2275651; Biolegend), IL-33R (T1/ST2, clone DJ8, # 101001B, RRID: AB_947551; MD Biosciences), TL1A (clone Tandys1a, # 46-7911-82, RRID: AB_11217878; eBioscience), EpCAM (CD326, clone G8.8, # 118205, RRID: AB_1134176; BioLegend), CD31 (clone MEC13.3, # 102513; RRID: AB_493413; BioLegend), TCR beta (clone H57-597, # 48-5961-80, RRID:AB_11062012; eBioscience), and TCR gamma/delta (clone eBioGL3, # 48-5711-82, RRID:AB_2574071; eBioscience). .. Antibodies were diluted in FcR block (CD16/CD32 clone 2.4G2, # 553142, RRID: AB_394657; BD Biosciences) for 30 min at 4°C.

    Blocking Assay:

    Article Title: Neuroimmune characterization of optineurin insufficiency mouse model during ageing.
    Article Snippet: TMB (#ES001-500ML) was from Merck Millipore (Burlington, MA, USA). .. Flow cytometry anti-mouse antibodies against B220 (#103231), CD8a (#100744), CD25 (#101910), CD38 (#102707), CD44 (#103055), CD62L (#104431), CD69 (#104514), CD90.2 (#105331), FOXP3 (126404), IFN-γ (#505845), Ly-6G (#127606), MHC Class II (#107648) and NK.1.1 (#108739) were from BioLegend (San Diego, CA, USA), CD11c (#12-0114-82), CD45 (#11-0451-82), CD86 (#25-0862-80), F4/80 (#45-4801-82), KLRG1 (#11-5893-82), Ly-6C (#47-5932-82), TNF-α (#25-7321-82), IL17A (#12-7177-81), IL-2 (#17-7021-81), and FOXP3/Transcription Factor Staining Buffer Set (#00-5523-00), and Live/Dead dye (#65-0863-14) were purchased from eBioscience (San Diego, CA, USA); CD4 (#560181), CD11b (#553312), 2.4G2 (Fc block, #553142) and Perm/Wash Buffer (#554723) were from BD Pharmingen (San Diego, CA, USA). .. Perm/Wash buffer (#51-2091KZ) was from BD Biosciences (Franklin Lakes, NJ, USA).

    Article Title: TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation
    Article Snippet: In some experiments , increasing doses of a STAT5 inhibitor (STAT5i; CAS 285986-31-4; # 573108; Calbiochem) were added to ILC2s stimulated with rIL-33, rTL1A, and rIL-2. .. Single-cell suspensions were stained for 30 min at 4°C with combinations of the following antibodies, diluted in FcR block (CD16/CD32 clone 2.4G2, # 553142, RRID: AB_394657; BD Biosciences): CD45 (clone 30F11, # 557235, RRID: AB_396609; BD Biosciences and # 17-0451-82, RRID: AB_469392; eBioscience), SiglecF (clone E50-2440, # 552126, RRID: AB_394341; BD Biosciences), CD4 (clone GK1.5, # 11-0041-85, RRID: AB_464892; eBioscience), CD19 (clone eBio1D3, # 561740, RRID: AB_396681; BD Biosciences), CD45R (clone RA3-6B2, # 553088, RRID: AB_394618; BD biosciences), NK1.1 (clone PK136, # 11-5941-85, RRID: AB_465318; eBioscience and # 108739, RRID:AB_2562273; Biolegend), CD3 (clone 17A2, # 11-0032-82, RRID: AB_2572431; eBioscience and eF450 # 48-0032-82, RRID: AB_1272193; eBioscience), CD11b (clone M1/70, # 11-0112-85, RRID: AB_464936; eBioscience), Ter119 (clone Ter119, # 11-5921-85, RRID: AB_465311; eBioscience), Ly-6G/Ly6C (Gr-1, clone RB6-8C5, # 11-5931-81, RRID: AB_465313; eBioscience), FcεRIa (clone MAR-1, # 11-5898-85, RRID: AB_465308; eBioscience), CD11c (clone N418, # 11-0114-85, RRID: AB_464941; eBioscience and # 17-0114-82, RRID: AB_469346), CD90.2 (clone 53–2.1, # 561641, RRID: AB_10898013; BD Biosciences), Sca-1 (clone D7, # 17-5981-83, RRID: AB_469488; eBioscience), CD25 (clone PC61.5, # 48-0251-82, RRID: AB_10671550; eBioscience), CD127 (clone A7R34, # 12-1,271-82, RRID: AB_465844; eBioscience), KLRG1 (clone 2F1, # 17-5893-81, RRID: AB_469469; eBioscience), ICOS (clone 7E-17G9, # 12-9942-82, RRID: AB_466274; eBioscience), DR3 (clone 4C12, # 144405, RRID: AB_2561688; Biolegend), CD200 (clone OX-90, # 123807, RRID: AB_2275651; Biolegend), IL-33R (T1/ST2, clone DJ8, # 101001B, RRID: AB_947551; MD Biosciences), TL1A (clone Tandys1a, # 46-7911-82, RRID: AB_11217878; eBioscience), EpCAM (CD326, clone G8.8, # 118205, RRID: AB_1134176; BioLegend), CD31 (clone MEC13.3, # 102513; RRID: AB_493413; BioLegend), TCR beta (clone H57-597, # 48-5961-80, RRID:AB_11062012; eBioscience), and TCR gamma/delta (clone eBioGL3, # 48-5711-82, RRID:AB_2574071; eBioscience). .. Antibodies were diluted in FcR block (CD16/CD32 clone 2.4G2, # 553142, RRID: AB_394657; BD Biosciences) for 30 min at 4°C.

    other:

    Article Title: SLAMF7 defines subsets of human effector CD8 T cells
    Article Snippet: KLRG1 , 2F12/KLRG1 , eBioscience , 1/25.

    Isolation:

    Article Title: Immunogenicity and protection of a triple repeat domain III mRNA vaccine against Zika virus.
    Article Snippet: Representative images of the histopathological sections were captured using Aperio ImageScope Version 12.3 (Leica Biosystems, Buffalo Grove, IL, USA), and evaluated by a blinded histopathologist to ensure unbiased analysis. .. To determine effector T cell and B cell and splenocytes were isolated, blocked using CD16/CD32 (eBioscience) for 20 min at 4 ◦C and stained with CD8a (clone 53–6.7, BioLegend, San Diego, CA, USA), CD4 (clone GK1.5, BioLegend), CD25 (clone PC61.5, BioLegend), CD69 (clone H1.2F3, BioLegend), CD127 (clone A7R34, BioLegend), KLRG1 (clone 2F1, Invitrogen), CD19 (clone eBio1D3, eBioscience), CD138 (clone 281–2(Syndecan-1), BD Horizon), C73 (clone eBioTY/11.8, eBioscience), GL7 (clone GL7, BioLegend) and Fixable Viability Dye eFluor520 (eBioscience) for 30 min at 4 ◦C in the dark. ..

    Recombinase Polymerase Amplification:

    Article Title: TCF-1 and TOX regulate the memory formation of intestinal group 2 innate lymphoid cells in asthma
    Article Snippet: For intracellular analysis, cells were treated with 1× Cell Stimulation Cocktail (plus protein transport inhibitors) (#00-4975-93; eBioscience) and the Foxp3/Transcription Factor Staining Buffer Set (#00-5523-00; eBioscience) according to the manufacturer’s instructions before antibody staining. .. To analyze human ILC2s, antibodies against CD45 (clone HI30; #MHCD4512; Invitrogen; 1:500), lineage markers (CD2, clone RPA-2.10, CD3, clone OKT3, CD14, clone 61D3, CD16, clone CB16, CD19, clone HIB19, CD56, clone TULY56, and CD235a, clone HIR2; #22-7778-72; eBioscience; 1:250), CRTH2 (clone BM16; #12-2949-41; eBioscience; 1:500), CD127 (clone eBioRDR5; #15-1278-42; Invitrogen; 1:500), GATA3 (clone TWAJ; #48-9966-42; Invitrogen; 1:200), ST2 (clone hIL33Rcap; #46-9338-42; Invitrogen; 1:200), KLRG1 (clone 47-9488-41; #47-9488-41; eBioscience; 1:200), IL-17RB (clone 170220; #FAB1207A; R&D systems; 1:200), IL-13 (clone 85BRD; #51-7136-42; Invitrogen; 1:200), IL-5 (clone TRFK5; #48-7052-82; Invitrogen; 1:200), Ki-67 (clone SolA15; #53-5698-82; Invitrogen; 1:500) and corresponding isotype controls were applied. ..

    Single Cell:

    Article Title: TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation
    Article Snippet: In some experiments , increasing doses of a STAT5 inhibitor (STAT5i; CAS 285986-31-4; # 573108; Calbiochem) were added to ILC2s stimulated with rIL-33, rTL1A, and rIL-2. .. Single-cell suspensions were stained for 30 min at 4°C with combinations of the following antibodies, diluted in FcR block (CD16/CD32 clone 2.4G2, # 553142, RRID: AB_394657; BD Biosciences): CD45 (clone 30F11, # 557235, RRID: AB_396609; BD Biosciences and # 17-0451-82, RRID: AB_469392; eBioscience), SiglecF (clone E50-2440, # 552126, RRID: AB_394341; BD Biosciences), CD4 (clone GK1.5, # 11-0041-85, RRID: AB_464892; eBioscience), CD19 (clone eBio1D3, # 561740, RRID: AB_396681; BD Biosciences), CD45R (clone RA3-6B2, # 553088, RRID: AB_394618; BD biosciences), NK1.1 (clone PK136, # 11-5941-85, RRID: AB_465318; eBioscience and # 108739, RRID:AB_2562273; Biolegend), CD3 (clone 17A2, # 11-0032-82, RRID: AB_2572431; eBioscience and eF450 # 48-0032-82, RRID: AB_1272193; eBioscience), CD11b (clone M1/70, # 11-0112-85, RRID: AB_464936; eBioscience), Ter119 (clone Ter119, # 11-5921-85, RRID: AB_465311; eBioscience), Ly-6G/Ly6C (Gr-1, clone RB6-8C5, # 11-5931-81, RRID: AB_465313; eBioscience), FcεRIa (clone MAR-1, # 11-5898-85, RRID: AB_465308; eBioscience), CD11c (clone N418, # 11-0114-85, RRID: AB_464941; eBioscience and # 17-0114-82, RRID: AB_469346), CD90.2 (clone 53–2.1, # 561641, RRID: AB_10898013; BD Biosciences), Sca-1 (clone D7, # 17-5981-83, RRID: AB_469488; eBioscience), CD25 (clone PC61.5, # 48-0251-82, RRID: AB_10671550; eBioscience), CD127 (clone A7R34, # 12-1,271-82, RRID: AB_465844; eBioscience), KLRG1 (clone 2F1, # 17-5893-81, RRID: AB_469469; eBioscience), ICOS (clone 7E-17G9, # 12-9942-82, RRID: AB_466274; eBioscience), DR3 (clone 4C12, # 144405, RRID: AB_2561688; Biolegend), CD200 (clone OX-90, # 123807, RRID: AB_2275651; Biolegend), IL-33R (T1/ST2, clone DJ8, # 101001B, RRID: AB_947551; MD Biosciences), TL1A (clone Tandys1a, # 46-7911-82, RRID: AB_11217878; eBioscience), EpCAM (CD326, clone G8.8, # 118205, RRID: AB_1134176; BioLegend), CD31 (clone MEC13.3, # 102513; RRID: AB_493413; BioLegend), TCR beta (clone H57-597, # 48-5961-80, RRID:AB_11062012; eBioscience), and TCR gamma/delta (clone eBioGL3, # 48-5711-82, RRID:AB_2574071; eBioscience). .. Antibodies were diluted in FcR block (CD16/CD32 clone 2.4G2, # 553142, RRID: AB_394657; BD Biosciences) for 30 min at 4°C.

    FACS:

    Article Title: TCF-1 and TOX regulate the memory formation of intestinal group 2 innate lymphoid cells in asthma.
    Article Snippet: .. Flow cytometry and cell sorting To analyze mice ILC2s, different combinations of antibodies against lineage markers (CD3ε, clone 145-2C11, Ly-6G/Ly-6C, clone RB6-8C5, CD11b, clone M1/70, CD45R/B220, clone RA3-6B2, TER-119/Erythroid cells, clone Ter-119; #133302; BioLegend; 1:200), CD45 (clone 30-F11; #25-0451-82; eBioscience; 1:500), CD90.2/Thy1.2 (clone 53-2.1; #64- 0902-82; eBioscience; 1:500), NK1.1 (clone PK136; #414-5941-82; eBioscience; 1:500), NKp46/CD335 (clone 29A1.4; #48-3351-82; eBioscience; 1:500), CD4 (clone RM4-5; #Q22165; eBioscience; 1:500), IL-33R/ST2 (clone RMST2-2; #63-9335-82; eBioscience; 1:200), GATA3 (clone TWAJ; #56-9966-42; eBioscience; 1:100), Rorγt (clone B2D; #61- 6981-82; eBioscience; 1:100), KLRG1 (clone 2F1; #46-5893-80; eBioscience; 1:200), IL-17RB (cloneMUNC33; #50-7361-82; eBioscience; 1:200), CD199/CCR9 (clone CW-1.2; #48-1991-82; eBioscience; 1:500), CD363/S1PR1 (clone SW4GYPP; #50-3639-42; eBioscience; 1:500), integrinα4β7 (clone DATK-32; #12-5887-82; eBioscience; 1:500), CD45.1 (clone A20; #48-0453-82; eBioscience; 1:500), Ki-67 (clone SolA15; #46- 5698-82; eBioscience; 1:500), IL-4 (clone 11B11; # 25-7041-82; eBioscience; 1:200), IL-5 (cloneTRFK5; #12-7052-81; eBioscience; 1:200), IL-13 (clone eBio13A; #47-7133-80; eBioscience; 1:200), TCF-1 (clone C.725.7; #MA5-14965; invitrogen; 1:200) and TOX (clone TXRX10; #12- 6502-82; Invitrogen; 1:200) or corresponding control isotypes were applied depending on the experiment. .. Cells were blocked with FcR Blocking Reagent (#130-092-575, Miltenyi Biotec), followed by 30min of staining with antibodies and with LIVE/DEAD Fixable aqua at 4 °C.

    Control:

    Article Title: TCF-1 and TOX regulate the memory formation of intestinal group 2 innate lymphoid cells in asthma.
    Article Snippet: .. Flow cytometry and cell sorting To analyze mice ILC2s, different combinations of antibodies against lineage markers (CD3ε, clone 145-2C11, Ly-6G/Ly-6C, clone RB6-8C5, CD11b, clone M1/70, CD45R/B220, clone RA3-6B2, TER-119/Erythroid cells, clone Ter-119; #133302; BioLegend; 1:200), CD45 (clone 30-F11; #25-0451-82; eBioscience; 1:500), CD90.2/Thy1.2 (clone 53-2.1; #64- 0902-82; eBioscience; 1:500), NK1.1 (clone PK136; #414-5941-82; eBioscience; 1:500), NKp46/CD335 (clone 29A1.4; #48-3351-82; eBioscience; 1:500), CD4 (clone RM4-5; #Q22165; eBioscience; 1:500), IL-33R/ST2 (clone RMST2-2; #63-9335-82; eBioscience; 1:200), GATA3 (clone TWAJ; #56-9966-42; eBioscience; 1:100), Rorγt (clone B2D; #61- 6981-82; eBioscience; 1:100), KLRG1 (clone 2F1; #46-5893-80; eBioscience; 1:200), IL-17RB (cloneMUNC33; #50-7361-82; eBioscience; 1:200), CD199/CCR9 (clone CW-1.2; #48-1991-82; eBioscience; 1:500), CD363/S1PR1 (clone SW4GYPP; #50-3639-42; eBioscience; 1:500), integrinα4β7 (clone DATK-32; #12-5887-82; eBioscience; 1:500), CD45.1 (clone A20; #48-0453-82; eBioscience; 1:500), Ki-67 (clone SolA15; #46- 5698-82; eBioscience; 1:500), IL-4 (clone 11B11; # 25-7041-82; eBioscience; 1:200), IL-5 (cloneTRFK5; #12-7052-81; eBioscience; 1:200), IL-13 (clone eBio13A; #47-7133-80; eBioscience; 1:200), TCF-1 (clone C.725.7; #MA5-14965; invitrogen; 1:200) and TOX (clone TXRX10; #12- 6502-82; Invitrogen; 1:200) or corresponding control isotypes were applied depending on the experiment. .. Cells were blocked with FcR Blocking Reagent (#130-092-575, Miltenyi Biotec), followed by 30min of staining with antibodies and with LIVE/DEAD Fixable aqua at 4 °C.

    Article Title: TCF-1 and TOX regulate the memory formation of intestinal group 2 innate lymphoid cells in asthma
    Article Snippet: .. To analyze mice ILC2s, different combinations of antibodies against lineage markers (CD3ε, clone 145-2C11, Ly-6G/Ly-6C, clone RB6-8C5, CD11b, clone M1/70, CD45R/B220, clone RA3-6B2, TER-119/Erythroid cells, clone Ter-119; #133302; BioLegend; 1:200), CD45 (clone 30-F11; #25-0451-82; eBioscience; 1:500), CD90.2/Thy1.2 (clone 53-2.1; #64-0902-82; eBioscience; 1:500), NK1.1 (clone PK136; #414-5941-82; eBioscience; 1:500), NKp46/CD335 (clone 29A1.4; #48-3351-82; eBioscience; 1:500), CD4 (clone RM4-5; #Q22165; eBioscience; 1:500), IL-33R/ST2 (clone RMST2-2; #63-9335-82; eBioscience; 1:200), GATA3 (clone TWAJ; #56-9966-42; eBioscience; 1:100), Rorγt (clone B2D; #61-6981-82; eBioscience; 1:100), KLRG1 (clone 2F1; #46-5893-80; eBioscience; 1:200), IL-17RB (clone MUNC33; #50-7361-82; eBioscience; 1:200), CD199/CCR9 (clone CW-1.2; #48-1991-82; eBioscience; 1:500), CD363/S1PR1 (clone SW4GYPP; #50-3639-42; eBioscience; 1:500), integrin α4β7 (clone DATK-32; #12-5887-82; eBioscience; 1:500), CD45.1 (clone A20; #48-0453-82; eBioscience; 1:500), Ki-67 (clone SolA15; #46-5698-82; eBioscience; 1:500), IL-4 (clone 11B11; # 25-7041-82; eBioscience; 1:200), IL-5 (clone TRFK5; #12-7052-81; eBioscience; 1:200), IL-13 (clone eBio13A; #47-7133-80; eBioscience; 1:200), TCF-1 (clone C.725.7; #MA5-14965; invitrogen; 1:200) and TOX (clone TXRX10; #12-6502-82; Invitrogen; 1:200) or corresponding control isotypes were applied depending on the experiment. .. Cells were blocked with FcR Blocking Reagent (#130-092-575, Miltenyi Biotec), followed by 30 min of staining with antibodies and with LIVE/DEAD Fixable aqua at 4 °C.



    Similar Products

    93
    Miltenyi Biotec klrg1 antibody, anti-human, reafinity
    Klrg1 Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/klrg1/KLRG1+Antibody%2C+anti-human%2C+REAfinity/custom%40130-126-458%4042526444
    Average 93 stars, based on 1 article reviews
    klrg1 antibody, anti-human, reafinity - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec klrg1
    Klrg1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/klrg1/KLRG1+Antibody%2C+anti-mouse/us12601683-167-25-28
    Average 94 stars, based on 1 article reviews
    klrg1 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec resource source identifier klrg1 apc
    Resource Source Identifier Klrg1 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/klrg1/KLRG1+Antibody%2C+anti-human%2C+REAfinity/pm41886458-25-7-15
    Average 93 stars, based on 1 article reviews
    resource source identifier klrg1 apc - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec klrg1 apc
    Klrg1 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/klrg1/KLRG1+Antibody%2C+anti-mouse/pm41776652-82-27-30
    Average 94 stars, based on 1 article reviews
    klrg1 apc - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Cytek Biosciences klrg1 apc
    (A) Gating strategy and quantification of naive (N), effector (E), central memory (CM), and CD62L − CD44 lo CD4 + T cell populations ( n = 5). (B–E) Cell surface expression and representative histograms on CD4 + T cells ( n = 5): (B) CD39, (C) CD69, (D) <t>KLRG1,</t> and (E) PD-1. Line in flow plots represents where positivity was determined. (F–H) Intracellular expression and representative histograms of transcription factors in the indicated CD4 + T cells ( n = 3–4) (F) Tbet, (G) Tox, and (H) Foxp3. (I) Gating strategy for CD11b/CD27 NK cell maturation subtypes ( n = 3). (J) Cell surface expression and representative histogram of CXCR3 in NK cells ( n = 3/group). YC, YL, AC, AL are defined in . Data are mean ± SEM and are analyzed by a two-way ANOVA and Sidak’s test (A and I) or Student’s t test (B–H and J). Data are compiled from at least two independent experiments, and each dot represents an individual mouse. * p < 0.05 ** p < 0.01, and *** p < 0.001, **** p < 0.0001, n.s. = not significant. See also and .
    Klrg1 Apc, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/klrg1/APC+Anti-Mouse+KLRG1/pmc12903672-7-0-4
    Average 93 stars, based on 1 article reviews
    klrg1 apc - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    R&D Systems monoclonal mouse anti ido 1 antibody
    (A) Gating strategy and quantification of naive (N), effector (E), central memory (CM), and CD62L − CD44 lo CD4 + T cell populations ( n = 5). (B–E) Cell surface expression and representative histograms on CD4 + T cells ( n = 5): (B) CD39, (C) CD69, (D) <t>KLRG1,</t> and (E) PD-1. Line in flow plots represents where positivity was determined. (F–H) Intracellular expression and representative histograms of transcription factors in the indicated CD4 + T cells ( n = 3–4) (F) Tbet, (G) Tox, and (H) Foxp3. (I) Gating strategy for CD11b/CD27 NK cell maturation subtypes ( n = 3). (J) Cell surface expression and representative histogram of CXCR3 in NK cells ( n = 3/group). YC, YL, AC, AL are defined in . Data are mean ± SEM and are analyzed by a two-way ANOVA and Sidak’s test (A and I) or Student’s t test (B–H and J). Data are compiled from at least two independent experiments, and each dot represents an individual mouse. * p < 0.05 ** p < 0.01, and *** p < 0.001, **** p < 0.0001, n.s. = not significant. See also and .
    Monoclonal Mouse Anti Ido 1 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/klrg1/Mouse+KLRG1+Antibody/pm40710094-88-7-30
    Average 93 stars, based on 1 article reviews
    monoclonal mouse anti ido 1 antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec anti human klrg1 pe vio770
    (A) Gating strategy and quantification of naive (N), effector (E), central memory (CM), and CD62L − CD44 lo CD4 + T cell populations ( n = 5). (B–E) Cell surface expression and representative histograms on CD4 + T cells ( n = 5): (B) CD39, (C) CD69, (D) <t>KLRG1,</t> and (E) PD-1. Line in flow plots represents where positivity was determined. (F–H) Intracellular expression and representative histograms of transcription factors in the indicated CD4 + T cells ( n = 3–4) (F) Tbet, (G) Tox, and (H) Foxp3. (I) Gating strategy for CD11b/CD27 NK cell maturation subtypes ( n = 3). (J) Cell surface expression and representative histogram of CXCR3 in NK cells ( n = 3/group). YC, YL, AC, AL are defined in . Data are mean ± SEM and are analyzed by a two-way ANOVA and Sidak’s test (A and I) or Student’s t test (B–H and J). Data are compiled from at least two independent experiments, and each dot represents an individual mouse. * p < 0.05 ** p < 0.01, and *** p < 0.001, **** p < 0.0001, n.s. = not significant. See also and .
    Anti Human Klrg1 Pe Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/klrg1/KLRG1+Antibody%2C+anti-human%2C+REAfinity/pmc12318227-195-73-78
    Average 93 stars, based on 1 article reviews
    anti human klrg1 pe vio770 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher pe-cyanine7 klrg1 monoclonal antibody (2f1)
    Defective ILC3 function in IRF4-deficient mice drives C. rodentium and C. albicans infection in a cell-intrinsic manner (A–F) NCG mice were adoptively transferred with 80,000 intestinal ILC3s (Lin − CD127 + CD27 − <t>KLRG1</t> − ) sorted from the small intestine of Irf4 f/f and Irf4 f/f Rorc cre mice or PBS as control after being treated with ABX for 1 week. ILC3s were stimulated with IL-23 and IL-1β for 30 min before injected into NCG mice through the tail vein. NCG mice were orally inoculated with C. rodentium 24 h after adoptive transfer. (A, B) Measurements (A) and statistical analysis (B) of the colon lengths from NCG recipients ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (C) CFUs in the feces of NCG recipients 9 days after infection ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (D) Changes in body weight were recorded at the indicated time points ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (E) H&E staining of colon tissue sections. (F) Pathological score of colon histology. (G–L) Irf4 f/f or Irf4 f/f Rorc cre ILC3s were adoptively transferred into NCG mice with C. albicans infection. (G and H) Measurements (G) and statistical analysis (H) of the colon lengths from NCG recipients ( n = 2 control, n = 4 transferred). (I) Fecal fungal burden ( n = 3 control, n = 4 transferred). (J) Variations of body weight were shown each day ( n = 4). (K) Pathological score of colon histology. (L) Histological analysis of colonic tissues by H&E staining. The data are representative of at least two independent experiments (A–L). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .
    Pe Cyanine7 Klrg1 Monoclonal Antibody (2f1), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/klrg1/anti+klrg1/pmc12205599-22-0-6
    Average 90 stars, based on 1 article reviews
    pe-cyanine7 klrg1 monoclonal antibody (2f1) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    86
    Thermo Fisher gene exp klrg1 hs00195153 m1
    Defective ILC3 function in IRF4-deficient mice drives C. rodentium and C. albicans infection in a cell-intrinsic manner (A–F) NCG mice were adoptively transferred with 80,000 intestinal ILC3s (Lin − CD127 + CD27 − <t>KLRG1</t> − ) sorted from the small intestine of Irf4 f/f and Irf4 f/f Rorc cre mice or PBS as control after being treated with ABX for 1 week. ILC3s were stimulated with IL-23 and IL-1β for 30 min before injected into NCG mice through the tail vein. NCG mice were orally inoculated with C. rodentium 24 h after adoptive transfer. (A, B) Measurements (A) and statistical analysis (B) of the colon lengths from NCG recipients ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (C) CFUs in the feces of NCG recipients 9 days after infection ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (D) Changes in body weight were recorded at the indicated time points ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (E) H&E staining of colon tissue sections. (F) Pathological score of colon histology. (G–L) Irf4 f/f or Irf4 f/f Rorc cre ILC3s were adoptively transferred into NCG mice with C. albicans infection. (G and H) Measurements (G) and statistical analysis (H) of the colon lengths from NCG recipients ( n = 2 control, n = 4 transferred). (I) Fecal fungal burden ( n = 3 control, n = 4 transferred). (J) Variations of body weight were shown each day ( n = 4). (K) Pathological score of colon histology. (L) Histological analysis of colonic tissues by H&E staining. The data are representative of at least two independent experiments (A–L). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .
    Gene Exp Klrg1 Hs00195153 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/klrg1/Gene+Exp%2E+klrg1+hs00195153+m1/pmc09898569__41467_2023_36193_MOESM1_ESM-137-127--1
    Average 86 stars, based on 1 article reviews
    gene exp klrg1 hs00195153 m1 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    Image Search Results


    (A) Gating strategy and quantification of naive (N), effector (E), central memory (CM), and CD62L − CD44 lo CD4 + T cell populations ( n = 5). (B–E) Cell surface expression and representative histograms on CD4 + T cells ( n = 5): (B) CD39, (C) CD69, (D) KLRG1, and (E) PD-1. Line in flow plots represents where positivity was determined. (F–H) Intracellular expression and representative histograms of transcription factors in the indicated CD4 + T cells ( n = 3–4) (F) Tbet, (G) Tox, and (H) Foxp3. (I) Gating strategy for CD11b/CD27 NK cell maturation subtypes ( n = 3). (J) Cell surface expression and representative histogram of CXCR3 in NK cells ( n = 3/group). YC, YL, AC, AL are defined in . Data are mean ± SEM and are analyzed by a two-way ANOVA and Sidak’s test (A and I) or Student’s t test (B–H and J). Data are compiled from at least two independent experiments, and each dot represents an individual mouse. * p < 0.05 ** p < 0.01, and *** p < 0.001, **** p < 0.0001, n.s. = not significant. See also and .

    Journal: Cancer cell

    Article Title: Lymphoma accelerates T cell and tissue aging

    doi: 10.1016/j.ccell.2025.07.023

    Figure Lengend Snippet: (A) Gating strategy and quantification of naive (N), effector (E), central memory (CM), and CD62L − CD44 lo CD4 + T cell populations ( n = 5). (B–E) Cell surface expression and representative histograms on CD4 + T cells ( n = 5): (B) CD39, (C) CD69, (D) KLRG1, and (E) PD-1. Line in flow plots represents where positivity was determined. (F–H) Intracellular expression and representative histograms of transcription factors in the indicated CD4 + T cells ( n = 3–4) (F) Tbet, (G) Tox, and (H) Foxp3. (I) Gating strategy for CD11b/CD27 NK cell maturation subtypes ( n = 3). (J) Cell surface expression and representative histogram of CXCR3 in NK cells ( n = 3/group). YC, YL, AC, AL are defined in . Data are mean ± SEM and are analyzed by a two-way ANOVA and Sidak’s test (A and I) or Student’s t test (B–H and J). Data are compiled from at least two independent experiments, and each dot represents an individual mouse. * p < 0.05 ** p < 0.01, and *** p < 0.001, **** p < 0.0001, n.s. = not significant. See also and .

    Article Snippet: KLRG1 – APC , Tonbo , Cat # 20-5893; RRID:AB_2621607.

    Techniques: Expressing

    Defective ILC3 function in IRF4-deficient mice drives C. rodentium and C. albicans infection in a cell-intrinsic manner (A–F) NCG mice were adoptively transferred with 80,000 intestinal ILC3s (Lin − CD127 + CD27 − KLRG1 − ) sorted from the small intestine of Irf4 f/f and Irf4 f/f Rorc cre mice or PBS as control after being treated with ABX for 1 week. ILC3s were stimulated with IL-23 and IL-1β for 30 min before injected into NCG mice through the tail vein. NCG mice were orally inoculated with C. rodentium 24 h after adoptive transfer. (A, B) Measurements (A) and statistical analysis (B) of the colon lengths from NCG recipients ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (C) CFUs in the feces of NCG recipients 9 days after infection ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (D) Changes in body weight were recorded at the indicated time points ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (E) H&E staining of colon tissue sections. (F) Pathological score of colon histology. (G–L) Irf4 f/f or Irf4 f/f Rorc cre ILC3s were adoptively transferred into NCG mice with C. albicans infection. (G and H) Measurements (G) and statistical analysis (H) of the colon lengths from NCG recipients ( n = 2 control, n = 4 transferred). (I) Fecal fungal burden ( n = 3 control, n = 4 transferred). (J) Variations of body weight were shown each day ( n = 4). (K) Pathological score of colon histology. (L) Histological analysis of colonic tissues by H&E staining. The data are representative of at least two independent experiments (A–L). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .

    Journal: iScience

    Article Title: The transcription factor IRF4 regulates the homeostasis and function of intestinal ILC3s

    doi: 10.1016/j.isci.2025.112800

    Figure Lengend Snippet: Defective ILC3 function in IRF4-deficient mice drives C. rodentium and C. albicans infection in a cell-intrinsic manner (A–F) NCG mice were adoptively transferred with 80,000 intestinal ILC3s (Lin − CD127 + CD27 − KLRG1 − ) sorted from the small intestine of Irf4 f/f and Irf4 f/f Rorc cre mice or PBS as control after being treated with ABX for 1 week. ILC3s were stimulated with IL-23 and IL-1β for 30 min before injected into NCG mice through the tail vein. NCG mice were orally inoculated with C. rodentium 24 h after adoptive transfer. (A, B) Measurements (A) and statistical analysis (B) of the colon lengths from NCG recipients ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (C) CFUs in the feces of NCG recipients 9 days after infection ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (D) Changes in body weight were recorded at the indicated time points ( n = 4 control, n = 5 WT transferred, n = 7 KO transferred). (E) H&E staining of colon tissue sections. (F) Pathological score of colon histology. (G–L) Irf4 f/f or Irf4 f/f Rorc cre ILC3s were adoptively transferred into NCG mice with C. albicans infection. (G and H) Measurements (G) and statistical analysis (H) of the colon lengths from NCG recipients ( n = 2 control, n = 4 transferred). (I) Fecal fungal burden ( n = 3 control, n = 4 transferred). (J) Variations of body weight were shown each day ( n = 4). (K) Pathological score of colon histology. (L) Histological analysis of colonic tissues by H&E staining. The data are representative of at least two independent experiments (A–L). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .

    Article Snippet: PE-Cyanine7 KLRG1 Monoclonal Antibody (2F1) , eBioscience , Cat# 25-5893-82; RRID: AB_1518768.

    Techniques: Infection, Control, Injection, Adoptive Transfer Assay, Staining, Two Tailed Test

    IRF4 deficiency compromises MHC class Ⅱ expression and further restrains ILC-mediated apoptosis of effector CD4 + T cells both in vitro and in vivo (A) Violin plots visualizing the expression of MHC-class-Ⅱ-related signature genes. (B) FACS analysis and MFI of MHC class Ⅱ expression in ILC3s isolated from Irf4 f/f and Irf4 f/f Rorc cre mice ( n = 6). ILC3 subsets were gated as Lin − RORγt + and then CCR6 + NKp46 − , CCR6 − NKp46 + , or CCR6 − NKp46 − . The lineage cocktail included TCRγδ, CD3ε, CD19, CD5, CD11c, Gr-1, and Ter119. (C and D) Activated OT-Ⅱ CD4 + T cells were cultured ex vivo with purified ILC3s from the siLP of Irf4 f/f and Irf4 f/f Rorc cre mice in the presence or absence of Ova peptide or the anti-MHC class Ⅱ neutralizing antibody. (C) Quantification of OT-Ⅱ T cells recovery (%). (D) Quantification of Annexin-V + OT-Ⅱ T cells. (E and F) Naive CD4-positive T cells (gating as CD4 + CD25 − CD62L hi CD44 lo cells) were sorted from OT-Ⅱ mice and pre-activated overnight. After pre-activation, CD4 positive T cells were transplanted into recipient Irf4 f/f and Irf4 f/f Rorc cre mice along with OVA peptide administration every 2 days following transfer. Nine days later, mice were sacrificed for further analysis of OT-Ⅱ CD4 + T cells (gating as CD8 − CD4 + TCRβ + Vβ5 + ) transferred in the spleen, mLN, siLPL, and cLPL of recipient mice. (G) One hundred thousand intestinal ILC3s (Lin − CD127 + CD27 − KLRG1 − ) were sorted from Irf4 f/f or Irf4 f/f Rorc cre mice and transferred with 500,000 activated OT-ⅡCD4 + T cells into NCG mice, flowing by OVA peptide i.p. every 2 days. Nine days later, survived OT-ⅡCD4 + T cells were quantified. ( n = 2 APC, n = 5 transferred group). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. The data are representative of at least three independent experiments (B–G). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .

    Journal: iScience

    Article Title: The transcription factor IRF4 regulates the homeostasis and function of intestinal ILC3s

    doi: 10.1016/j.isci.2025.112800

    Figure Lengend Snippet: IRF4 deficiency compromises MHC class Ⅱ expression and further restrains ILC-mediated apoptosis of effector CD4 + T cells both in vitro and in vivo (A) Violin plots visualizing the expression of MHC-class-Ⅱ-related signature genes. (B) FACS analysis and MFI of MHC class Ⅱ expression in ILC3s isolated from Irf4 f/f and Irf4 f/f Rorc cre mice ( n = 6). ILC3 subsets were gated as Lin − RORγt + and then CCR6 + NKp46 − , CCR6 − NKp46 + , or CCR6 − NKp46 − . The lineage cocktail included TCRγδ, CD3ε, CD19, CD5, CD11c, Gr-1, and Ter119. (C and D) Activated OT-Ⅱ CD4 + T cells were cultured ex vivo with purified ILC3s from the siLP of Irf4 f/f and Irf4 f/f Rorc cre mice in the presence or absence of Ova peptide or the anti-MHC class Ⅱ neutralizing antibody. (C) Quantification of OT-Ⅱ T cells recovery (%). (D) Quantification of Annexin-V + OT-Ⅱ T cells. (E and F) Naive CD4-positive T cells (gating as CD4 + CD25 − CD62L hi CD44 lo cells) were sorted from OT-Ⅱ mice and pre-activated overnight. After pre-activation, CD4 positive T cells were transplanted into recipient Irf4 f/f and Irf4 f/f Rorc cre mice along with OVA peptide administration every 2 days following transfer. Nine days later, mice were sacrificed for further analysis of OT-Ⅱ CD4 + T cells (gating as CD8 − CD4 + TCRβ + Vβ5 + ) transferred in the spleen, mLN, siLPL, and cLPL of recipient mice. (G) One hundred thousand intestinal ILC3s (Lin − CD127 + CD27 − KLRG1 − ) were sorted from Irf4 f/f or Irf4 f/f Rorc cre mice and transferred with 500,000 activated OT-ⅡCD4 + T cells into NCG mice, flowing by OVA peptide i.p. every 2 days. Nine days later, survived OT-ⅡCD4 + T cells were quantified. ( n = 2 APC, n = 5 transferred group). Bar graphs are presented as mean ± SEM. A two-tailed Student’s t test was performed for comparisons. The data are representative of at least three independent experiments (B–G). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. See also .

    Article Snippet: PE-Cyanine7 KLRG1 Monoclonal Antibody (2F1) , eBioscience , Cat# 25-5893-82; RRID: AB_1518768.

    Techniques: Expressing, In Vitro, In Vivo, Isolation, Cell Culture, Ex Vivo, Purification, Activation Assay, Two Tailed Test